作者:
Diallo, Aldiouma [1]
;
Sow, Samba O. [2]
;
Idoko, Olubukola T. [3]
;
Hirve, Siddhivinayak [4]
;
Findlow, Helen [5]
;
Preziosi, Marie-Pierre [6]
;
Elie, Cheryl [7]
;
Kulkarni, Prasad S. [8]
;
Parulekar, Varsha [9]
;
Diarra, Bou [10]
;
Haidara, Fadima Cheick [11]
;
Diallo, Fatoumata [12]
;
Tapia, Milagritos ;
Akinsola, Adebayo K. ;
Adegbola, Richard A. ;
Bavdekar, Ashish ;
Juvekar, Sanjay ;
Chaumont, Julie ;
Martellet, Lionel ;
Marchetti, Elisa ;
LaForce, Marc F. ;
Plikaytis, Brian D. ;
Enwere, Godwin C. ;
Tang, Yuxiao ;
Borrow, Ray ;
Carlone, George ;
Viviani, Simonetta
作者单位:
Manchester Royal Infirm, Vaccine Evaluat Unit, Publ Hlth England, Manchester, Lancs, England
[1]
Ctr Dis Control & Prevent, Atlanta, GA USA
[2]
Minist Sante, Ctr Dev Vaccins, Bamako, Mali
[3]
MRC Labs, Basse, Gambia
[4]
Inst Rech Dev, Niakhar, Senegal
[5]
Univ Maryland, Sch Med, Dept Pediat, Ctr Vaccine Dev, Baltimore, MD 21201 USA
[6]
Shirdi Sai Baba Hosp, Vadu King Edward Mem Hosp & Res Ctr, Pune, Maharashtra, India
[7]
Serum Inst India Ltd, Pune, Maharashtra, India
[8]
GlaxoSmithKline Vaccines, Wavre, Belgium
[9]
DiagnoSearch Life Sci, Bombay, Maharashtra, India
[10]
PATH, Meningitis Vaccine Project, Ferney Voltaire, France
[11]
PATH, Meningitis Vaccine Project, Seattle, WA USA
[12]
发布时间
2017-04-06